Showing results (281-290 of 344) with videos related to
Sort By:
Pageof 35
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.Journal of Hepatology|December 3, 2013
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.Annals of Hepatology|May 29, 2016
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis CXavier Forns, Samuel Didier, David Mutimer, et al.Journal of Hepatology|June 12, 2020
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Roberta D'Ambrosio, Alessandro Soria, et al.The Journal of Clinical Endocrinology and Metabolism|December 31, 2021
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver DiseaseSami Qadri, Noora Ahlholm, Ida Lønsmann, et al.Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.Small (Weinheim an Der Bergstrasse, Germany)|October 22, 2020
Non-Equilibrium Synthesis of Highly Active Nanostructured, Oxygen-Incorporated Amorphous Molybdenum Sulfide HER ElectrocatalystGiorgio Giuffredi, Alessandro Mezzetti, Andrea Perego, et al.Nature Communications|April 11, 2017
Light-assisted delithiation of lithium iron phosphate nanocrystals towards photo-rechargeable lithium ion batteriesAndrea Paolella, Cyril Faure, Giovanni Bertoni, et al.Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.Pageof 35